登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，3月27日，Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-28

  • Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

    Tao Guo, MD1; Yongzhen Fan, MD1; Ming Chen, MD1; et al Xiaoyan Wu, MD1; Lin Zhang, MD1; Tao He, MD1; Hairong Wang, MD1; Jing Wan, MD1; Xinghuan Wang, MD2; Zhibing Lu, MD1

    Author Affiliations Article Information

    JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1017

    Key Points

    Question What is the impact of underlying cardiovascular disease (CVD) and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19)?

    Findings In this case series study of 187 patients with COVID-19, 27.8% of patients had myocardial injury, which resulted in cardiac dysfunction and arrhythmias. Myocardial injury has a significant association with fatal outcome of COVID-19, while the prognosis of patients with underlying CVD but without myocardial injury were relatively favorable.

  • 原文来源：https://jamanetwork.com/journals/jamacardiology/fullarticle/2763845?resultClick=1
19浏览量
原文链接
相关报告

  • 《JAMA，4月3日，Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-04-06
    • Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers Chirag Bavishi, MD, MPH1; Thomas M. Maddox, MD, MSc2,3; Franz H. Messerli, MD4,5,6 Author Affiliations Article Information JAMA Cardiol. Published online April 3, 2020. doi:10.1001/jamacardio.2020.1282 The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already surpassed the combined mortality inflicted by the severe acute respiratory syndrome (SARS) epidemic of 2002 and 2003 and the Middle East respiratory syndrome (MERS) epidemic of 2013. The pandemic is spreading at an exponential rate, with millions of people across the globe at risk of contracting SARS-CoV-2. Initial reports suggest that hypertension, diabetes, and cardiovascular diseases were the most frequent comorbidities in affected patients, and case fatality rates tended to be high in these individuals. In the largest Chinese study to date,1 which included 44?672 confirmed cases, preexisting comorbidities that had high mortality rates included cardiovascular disease (10.5%), diabetes (7.3%), and hypertension (6.0%). Patients with such comorbidities are commonly treated with renin angiotensin system blockers, such as angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).
    110浏览量
    原文链接

  • 《JAMA，3月19日，Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-20
    • Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State Matt Arentz, MD1; Eric Yim, MD2; Lindy Klaff, MD2; et alSharukh Lokhandwala, MD, MSc2; Francis X. Riedo, MD2; Maria Chong, MD3; Melissa Lee, MD2 JAMA. Published online March 19, 2020. doi:10.1001/jama.2020.4326 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19), is an emerging health threat.1 Until February 2020, most cases were described in non-US health systems.2,3 One of the first deaths in the US was reported at Evergreen Hospital in Kirkland, Washington. Over the following weeks, multiple cases of COVID-19 were identified in the surrounding community and treated at Evergreen Hospital. Most were attributed to US transmission, and the majority were linked to exposures at a skilled nursing facility.
    66浏览量
    原文链接